Skip to main content
. Author manuscript; available in PMC: 2011 Jun 7.
Published in final edited form as: Gene Ther. 2008 May 8;15(19):1311–1320. doi: 10.1038/gt.2008.78

Figure 4.

Figure 4

Reverse transcriptase (RT)–PCR on the total RNA from eyecups of Abca4−/− mice treated with equine infectious anemia virus (EIAV)-ABCA4 vectors 2 weeks (lanes 2, 3) and 2 months (lanes 4–6) after subretinal injections. Upper panel: lane 1, untreated Abca4−/− mouse eyes; lane 2, Abca4−/− mouse eyes 2 weeks after EIAV-CMV-ABCR injection; lane 3, Abca4−/− mouse eyes 2 weeks after EIAV-bRho-ABCR injection; lane 4, Abca4−/− mouse eyes 2 months after EIAV-CMV-ABCR injection; lane 5, the same experiment as in lane 4 with a different isolate of the EIAV-CMV-ABCR virus; lane 6, Abca4−/− mouse eyes 2 months after EIAV-bRho-ABCR injection; lane 7, marker. Lower panel shows amplification of a 0.3 kb fragment of the actin gene from the same RNA isolates.